Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
ACXP · NASDAQ · Pharmaceutical Preparations
Acurx Pharmaceuticals (ACXP) · oqro.io/stocks/ACXP · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Insider trade · Traded Jan 6, 2025 · Filed Jan 8, 2025
CEO purchased ~$50K of ACXP shares in the open marketSourceInsider trade · Traded Jan 6, 2025 · Filed Jan 8, 2025
Director purchased ~$25K of ACXP shares in the open marketSourceInsider trade · Traded Jan 6, 2025 · Filed Jan 8, 2025
Director purchased ~$25K of ACXP shares in the open marketSourceInsider trade · Traded Jan 6, 2025 · Filed Jan 8, 2025
Director purchased ~$10K of ACXP shares in the open marketSourceInsider trade · Traded Jan 6, 2025 · Filed Jan 8, 2025
Director purchased ~$10K of ACXP shares in the open marketSourceInsider trade · Traded Jan 6, 2025 · Filed Jan 8, 2025
Director purchased ~$50K of ACXP shares in the open marketSource$0.96−0.025 (−2.54%)
Close of Nov 13, 2026, vs Nov 12 · end-of-day, not a live quote
